Theodoros Vassilakopoulos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Theodoros Vassilakopoulos has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
Dimitrios Toumpanakis
2nd Department of Critical Care Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece
15 shared publications- Vassiliki Karavana
Department of Pathology, Evangelismos Hospital, Athens, Greece
6 shared publications Konstantinos Loverdos
1st Department of Critical Care and Pulmonary Medicine and "Marianthi Simou" Applied Biomedical Research and Training Center, Medical School, Evangelismos Hospital, University of Athens, Athens, Greece
5 shared publicationsStamatios Theocharis
Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
5 shared publicationsVyronia Vassilakopoulou
1“Marianthi Simou” Applied Biomedical Research and Training Center, Medical School, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece
5 shared publicationsEleftheria Mizi
1“Marianthi Simou” Applied Biomedical Research and Training Center, Medical School, National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece
4 shared publications
Latest Publications
- Open Access
- 22 March 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (3) , 342
Acute Effects of High-Velocity Interval Cycling Versus Continuous Moderate-Intensity Cycling on Cognitive Function in Patients with Mild Cognitive Impairment
Background/Objectives: Physical exercise has emerged as a promising non-pharmacological intervention for cognitive dysfunction; however, the most effective mode of exercise remains unclear. This study aimed to investigate the acute effects of two cycling exercise protocols, (a) continuous aerobic/moderate-intensity (CA) and (b) high-velocity/low-resistance (high-cadence) interval (HVI), on cognitive and executive performance in patients with mild cognitive impairment (MCI). Methods: Seventeen patients (10 females and 7 males, age: 65.5 ± 8.85 years) diagnosed with MCI or early-stage Alzheimer’s disease (13 MCI and 4 eAD) participated in a random order in three different conditions: CA, HVI, and control/no exercise (CON). Cognitive parameters were assessed acutely before and after the completion of each condition. Results: Significant condition × time interactions were observed for both Montreal Cognitive Assessment (MoCA) and Frontal Assessment Battery (FAB) (p < 0.01). Higher scores (p < 0.01) for MoCA and FAB post-intervention were found compared to baseline in both exercise bouts, whereas no changes occurred in CON. Interestingly, when post-intervention scores were compared between conditions, cognitive performance was improved only in HVΙ compared to CON in MoCA (p < 0.01) and FAB (p < 0.001), revealing a stronger acute effect of HVI. Conclusions: A single bout of high-velocity, low-resistance (high-cadence) interval cycling acutely enhanced global cognition and executive function in individuals with MCI, exerting greater improvement compared to continuous aerobic exercise or control condition. These findings emphasize the potential utilization of HVI as an effective non-pharmacological intervention to acutely enhance cognitive performance in older adults with MCI.
- 22 March 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (3) , 342
Open AccessAcute Effects of High-Velocity Interval Cycling Versus Continuous Moderate-Intensity Cycling on Cognitive Function in Patients with Mild Cognitive Impairment
Background/Objectives: Physical exercise has emerged as a promising non-pharmacological intervention for cognitive dysfunction; however, the most effective mode of exercise remains unclear. This study aimed to investigate the acute effects of two cycling exercise protocols, (a) continuous aerobic/moderate-intensity (CA) and (b) high-velocity/low-resistance (high-cadence) interval (HVI), on cognitive and executive performance in patients with mild cognitive impairment (MCI). Methods: Seventeen patients (10 females and 7 males, age: 65.5 ± 8.85 years) diagnosed with MCI or early-stage Alzheimer’s disease (13 MCI and 4 eAD) participated in a random order in three different conditions: CA, HVI, and control/no exercise (CON). Cognitive parameters were assessed acutely before and after the completion of each condition. Results: Significant condition × time interactions were observed for both Montreal Cognitive Assessment (MoCA) and Frontal Assessment Battery (FAB) (p < 0.01). Higher scores (p < 0.01) for MoCA and FAB post-intervention were found compared to baseline in both exercise bouts, whereas no changes occurred in CON. Interestingly, when post-intervention scores were compared between conditions, cognitive performance was improved only in HVΙ compared to CON in MoCA (p < 0.01) and FAB (p < 0.001), revealing a stronger acute effect of HVI. Conclusions: A single bout of high-velocity, low-resistance (high-cadence) interval cycling acutely enhanced global cognition and executive function in individuals with MCI, exerting greater improvement compared to continuous aerobic exercise or control condition. These findings emphasize the potential utilization of HVI as an effective non-pharmacological intervention to acutely enhance cognitive performance in older adults with MCI.
- Open Access
- 31 January 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (4)
Resistive breathing aggravates cigarette smoke-induced pulmonary inflammation
Introduction: Resistive breathing (RB) is the hallmark of diseases of airway obstruction, especially during exacerbations, resulting in significant mechanical stress on the lung. RB induces pulmonary inflammation and injury in previously healthy animals. Whether RB exerts additional injurious effects when superimposed on cigarette smoke (CS) exposure is unknown. Methods: Adult mice were exposed to CS for 1 or 6 months, followed by RB for 24 h, induced through tracheal banding. Subsequently, respiratory system mechanics were assessed, bronchoalveolar lavage (BAL) was performed and cytokine levels were measured by ELISA in lung tissue samples. Surfactant protein D (SP-D) was measured in blood, and BAL and histology were performed. Emphysema was quantified by the mean linear intercept (Lm) and the destructive index (DI). Results: CS exposure for 1 and 6 months increased BAL cellularity (∼8-fold and ∼1.9-fold to air, respectively, p<0.01). RB aggravated BAL cellularity at both time points (p=0.025 and p=0.002 to CS) and increased MCP-1 levels at 1 month (p=0.002 to control). Histology revealed augmented focal membrane thickening at 1 month following combination of RB with CS exposure (p=0.011), while at 6 months emphysema was more severe after RB in CS-exposed mice (p=0.001 to CS for both Lm and DI). CS increased Sp-D levels in BAL (p<0.01 at both time points), while RB caused increased levels in blood (p<0.01 to CS). RB decreased static compliance at 1 month of air exposure (p=0.007). Conclusion: Combining resistive breathing with cigarette smoke exposure results in augmented inflammatory responses, increased lung injury and augmented emphysema.
- 31 January 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (4)
Open AccessResistive breathing aggravates cigarette smoke-induced pulmonary inflammation
Introduction: Resistive breathing (RB) is the hallmark of diseases of airway obstruction, especially during exacerbations, resulting in significant mechanical stress on the lung. RB induces pulmonary inflammation and injury in previously healthy animals. Whether RB exerts additional injurious effects when superimposed on cigarette smoke (CS) exposure is unknown. Methods: Adult mice were exposed to CS for 1 or 6 months, followed by RB for 24 h, induced through tracheal banding. Subsequently, respiratory system mechanics were assessed, bronchoalveolar lavage (BAL) was performed and cytokine levels were measured by ELISA in lung tissue samples. Surfactant protein D (SP-D) was measured in blood, and BAL and histology were performed. Emphysema was quantified by the mean linear intercept (Lm) and the destructive index (DI). Results: CS exposure for 1 and 6 months increased BAL cellularity (∼8-fold and ∼1.9-fold to air, respectively, p<0.01). RB aggravated BAL cellularity at both time points (p=0.025 and p=0.002 to CS) and increased MCP-1 levels at 1 month (p=0.002 to control). Histology revealed augmented focal membrane thickening at 1 month following combination of RB with CS exposure (p=0.011), while at 6 months emphysema was more severe after RB in CS-exposed mice (p=0.001 to CS for both Lm and DI). CS increased Sp-D levels in BAL (p<0.01 at both time points), while RB caused increased levels in blood (p<0.01 to CS). RB decreased static compliance at 1 month of air exposure (p=0.007). Conclusion: Combining resistive breathing with cigarette smoke exposure results in augmented inflammatory responses, increased lung injury and augmented emphysema.
- Open Access
- 7 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (3)
Mortality prevention as the centre of COPD management
COPD is a major healthcare problem and cause of mortality worldwide. COPD patients at increased mortality risk are those who are more symptomatic, have lower lung function and lower diffusing capacity of the lung for carbon monoxide, decreased exercise capacity, belong to the emphysematous phenotype and those who have concomitant bronchiectasis. Mortality risk seems to be greater in patients who experience COPD exacerbations and in those who suffer from concomitant cardiovascular and/or metabolic diseases. To predict the risk of death in COPD patients, several composite scores have been created using different parameters. In previous years, large studies (also called mega-trials) have evaluated the efficacy of different therapies on COPD mortality, but until recently only nonpharmaceutical interventions have proven to be effective. However, recent studies on fixed combinations of triple therapy (long-acting β-agonists, long-acting muscarinic antagonists and inhaled corticosteroids) have provided encouraging results, showing for the first time a reduction in mortality compared to dual therapies. The aim of the present review is to summarise available data regarding mortality risk in COPD patients and to describe pharmacological therapies that have shown effectiveness in reducing mortality.
- 7 March 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (3)
Open AccessMortality prevention as the centre of COPD management
COPD is a major healthcare problem and cause of mortality worldwide. COPD patients at increased mortality risk are those who are more symptomatic, have lower lung function and lower diffusing capacity of the lung for carbon monoxide, decreased exercise capacity, belong to the emphysematous phenotype and those who have concomitant bronchiectasis. Mortality risk seems to be greater in patients who experience COPD exacerbations and in those who suffer from concomitant cardiovascular and/or metabolic diseases. To predict the risk of death in COPD patients, several composite scores have been created using different parameters. In previous years, large studies (also called mega-trials) have evaluated the efficacy of different therapies on COPD mortality, but until recently only nonpharmaceutical interventions have proven to be effective. However, recent studies on fixed combinations of triple therapy (long-acting β-agonists, long-acting muscarinic antagonists and inhaled corticosteroids) have provided encouraging results, showing for the first time a reduction in mortality compared to dual therapies. The aim of the present review is to summarise available data regarding mortality risk in COPD patients and to describe pharmacological therapies that have shown effectiveness in reducing mortality.
- Open Access
- 13 October 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (10) , 1074
The Effects of a Short-Term Combined Exercise Program on Liver Steatosis Indices and the Lipidemic and Glycemic Profile in NAFLD Individuals: A Pilot Study
Non-alcoholic fatty liver disease (NAFLD) is a very common liver disease associated with obesity, unhealthy diet, and lack of physical exercise. Short-term aerobic or resistance exercise has been shown to result in reduced liver fat in patients with NAFLD; however, the impact of the combination of these types of exercise has received less attention. This study investigated the effect of a short-term (7 days) concurrent exercise training program performed daily on liver steatosis indices, as well as the glycemic and lipidemic profile of overweight/obese sedentary volunteers. Twenty adult patients (age: 47.3 ± 12.3 yrs, body mass index: 32.4 ± 3.4 kg/m2) with NAFLD, detected by ultrasound and hematological indices, participated in the study. Pre- and post-exercise intervention assessment included body weight (BW), waist circumference (WC), hip/waist ratio (H/W), Homeostasis Model Assessment Insulin Resistance (HOMA-IR), blood lipids, and steatosis indices. Fatty Liver Index, Lipid Accumulation Index, WC, H/W, triglycerides, and total cholesterol were improved (p < 0.05) post-exercise, while no differences (p > 0.05) were observed in BW, HOMA-IR, HDL, LDL, Hepatic Steatosis Index, and Framingham Steatosis Index compared to pre-exercise values. It is concluded that a 7-day combined exercise program can have beneficial effects on hepatic steatosis and central adiposity indices, independently of weight loss, in patients with NAFLD.
- 13 October 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (10) , 1074
Open AccessThe Effects of a Short-Term Combined Exercise Program on Liver Steatosis Indices and the Lipidemic and Glycemic Profile in NAFLD Individuals: A Pilot Study
Non-alcoholic fatty liver disease (NAFLD) is a very common liver disease associated with obesity, unhealthy diet, and lack of physical exercise. Short-term aerobic or resistance exercise has been shown to result in reduced liver fat in patients with NAFLD; however, the impact of the combination of these types of exercise has received less attention. This study investigated the effect of a short-term (7 days) concurrent exercise training program performed daily on liver steatosis indices, as well as the glycemic and lipidemic profile of overweight/obese sedentary volunteers. Twenty adult patients (age: 47.3 ± 12.3 yrs, body mass index: 32.4 ± 3.4 kg/m2) with NAFLD, detected by ultrasound and hematological indices, participated in the study. Pre- and post-exercise intervention assessment included body weight (BW), waist circumference (WC), hip/waist ratio (H/W), Homeostasis Model Assessment Insulin Resistance (HOMA-IR), blood lipids, and steatosis indices. Fatty Liver Index, Lipid Accumulation Index, WC, H/W, triglycerides, and total cholesterol were improved (p < 0.05) post-exercise, while no differences (p > 0.05) were observed in BW, HOMA-IR, HDL, LDL, Hepatic Steatosis Index, and Framingham Steatosis Index compared to pre-exercise values. It is concluded that a 7-day combined exercise program can have beneficial effects on hepatic steatosis and central adiposity indices, independently of weight loss, in patients with NAFLD.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64) , 446
Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients
Background: Telomere-related genes (TRG) mutations are detected in 30% of familial pulmonary fibrosis (FPF) and are also associated with personal/familial extra-pulmonary disease suggestive of short telomere syndrome (STS). Aim: to evaluate the prevalence of TRG mutations in a national cohort of interstitial lung disease (ILD) with suspected genetic predisposition in Greece and to define patients’ characteristics and impact on outcome.Methods: Genetic diagnoses made between December 2014-September 2019 in patients with FPF, pulmonary fibrosis at young age or personal and/or family extra-pulmonary disease suggestive of STS were analyzed. Results: 150 ILD patients, 73% male, age-at-diagnosis 67 years old, 33% non-smokers, 75% with definite/probable UIP or CPFE, 93% with dyspnea/cough, FVC% pred 75%, DLCO% pred 49% were tested; FPF was 65%, 19% young age, 21% personal and 17% family extra-pulmonary disease suggestive of STS; 21% were tested for more than 1 indication. TRG pathogenic variations were detected in 19 (13%): 13 in a familial, 3 in young age and 3 in extra-pulmonary disease suggestive of STS context as follows: TERT, TERC, RTEL1, PARN, NOP10, NHP2 in 8,5,2,2,1 and 1 respectively. No difference was detected in epidemiological-clinical-radiologic-functional characteristics between patients without and with mutations apart from age-at-diagnosis [69 vs 62 years, p<0.001)]. Patients with TRG mutations were deceased at a younger age compared to those without (70 vs 76 years respectively, p=0.045). GAP index was the only independent factor of survival (p=0.029).Conclusion: TRG mutations were detected in 13% of patients tested. TERT and TERC mutations were the most frequent.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64) , 446
Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients
Background: Telomere-related genes (TRG) mutations are detected in 30% of familial pulmonary fibrosis (FPF) and are also associated with personal/familial extra-pulmonary disease suggestive of short telomere syndrome (STS). Aim: to evaluate the prevalence of TRG mutations in a national cohort of interstitial lung disease (ILD) with suspected genetic predisposition in Greece and to define patients’ characteristics and impact on outcome.Methods: Genetic diagnoses made between December 2014-September 2019 in patients with FPF, pulmonary fibrosis at young age or personal and/or family extra-pulmonary disease suggestive of STS were analyzed. Results: 150 ILD patients, 73% male, age-at-diagnosis 67 years old, 33% non-smokers, 75% with definite/probable UIP or CPFE, 93% with dyspnea/cough, FVC% pred 75%, DLCO% pred 49% were tested; FPF was 65%, 19% young age, 21% personal and 17% family extra-pulmonary disease suggestive of STS; 21% were tested for more than 1 indication. TRG pathogenic variations were detected in 19 (13%): 13 in a familial, 3 in young age and 3 in extra-pulmonary disease suggestive of STS context as follows: TERT, TERC, RTEL1, PARN, NOP10, NHP2 in 8,5,2,2,1 and 1 respectively. No difference was detected in epidemiological-clinical-radiologic-functional characteristics between patients without and with mutations apart from age-at-diagnosis [69 vs 62 years, p<0.001)]. Patients with TRG mutations were deceased at a younger age compared to those without (70 vs 76 years respectively, p=0.045). GAP index was the only independent factor of survival (p=0.029).Conclusion: TRG mutations were detected in 13% of patients tested. TERT and TERC mutations were the most frequent.
- Open Access
- 1 July 2020
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 1679-1688
Spontaneous Breathing Through Increased Airway Resistance Augments Elastase-Induced Pulmonary Emphysema
Introduction: Resistive breathing (RB), the pathophysiologic hallmark of chronic obstructive pulmonary disease (COPD), especially during exacerbations, is associated with significant inflammation and mechanical stress on the lung. Mechanical forces are implicated in the progression of emphysema that is a major pathologic feature of COPD. We hypothesized that resistive breathing exacerbates emphysema. Methods: C57BL/6 mice were exposed to 0.75 units of pancreatic porcine elastase intratracheally to develop emphysema. Resistive breathing was applied by suturing a nylon band around the trachea to reduce surface area to half for the last 24 or 72 hours of a 21-day time period after elastase treatment in total. Following RB (24 or 72 hours), lung mechanics were measured and bronchoalveolar lavage (BAL) was performed. Emphysema was quantified by the mean linear intercept (Lm) and the destructive index (DI) in lung tissue sections. Results: Following 21 days of intratracheal elastase exposure, Lm and DI increased in lung tissue sections [Lm (μm), control 39.09± 0.76, elastase 62.05± 2.19, p=0.003 and DI, ctr 30.95± 2.75, elastase 73.12± 1.75, p< 0.001]. RB for 72 hours further increased Lm by 64% and DI by 19%, compared to elastase alone (p< 0.001 and p=0.02, respectively). RB induced BAL neutrophilia in elastase-treated mice. Static compliance (Cst) increased in elastase-treated mice [Cst (mL/cmH2O), control 0.067± 0.001, elastase 0.109± 0.006, p< 0.001], but superimposed RB decreased Cst, compared to elastase alone [Cst (mL/cmH2O), elastase+RB24h 0.090± 0.004, p=0.006 to elastase, elastase+RB72h 0.090± 0.005, p=0.006 to elastase]. Conclusion: Resistive breathing augments pulmonary inflammation and emphysema in an elastase-induced emphysema mouse model.
- 1 July 2020
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 15, 1679-1688
Open AccessSpontaneous Breathing Through Increased Airway Resistance Augments Elastase-Induced Pulmonary Emphysema
Introduction: Resistive breathing (RB), the pathophysiologic hallmark of chronic obstructive pulmonary disease (COPD), especially during exacerbations, is associated with significant inflammation and mechanical stress on the lung. Mechanical forces are implicated in the progression of emphysema that is a major pathologic feature of COPD. We hypothesized that resistive breathing exacerbates emphysema. Methods: C57BL/6 mice were exposed to 0.75 units of pancreatic porcine elastase intratracheally to develop emphysema. Resistive breathing was applied by suturing a nylon band around the trachea to reduce surface area to half for the last 24 or 72 hours of a 21-day time period after elastase treatment in total. Following RB (24 or 72 hours), lung mechanics were measured and bronchoalveolar lavage (BAL) was performed. Emphysema was quantified by the mean linear intercept (Lm) and the destructive index (DI) in lung tissue sections. Results: Following 21 days of intratracheal elastase exposure, Lm and DI increased in lung tissue sections [Lm (μm), control 39.09± 0.76, elastase 62.05± 2.19, p=0.003 and DI, ctr 30.95± 2.75, elastase 73.12± 1.75, p< 0.001]. RB for 72 hours further increased Lm by 64% and DI by 19%, compared to elastase alone (p< 0.001 and p=0.02, respectively). RB induced BAL neutrophilia in elastase-treated mice. Static compliance (Cst) increased in elastase-treated mice [Cst (mL/cmH2O), control 0.067± 0.001, elastase 0.109± 0.006, p< 0.001], but superimposed RB decreased Cst, compared to elastase alone [Cst (mL/cmH2O), elastase+RB24h 0.090± 0.004, p=0.006 to elastase, elastase+RB72h 0.090± 0.005, p=0.006 to elastase]. Conclusion: Resistive breathing augments pulmonary inflammation and emphysema in an elastase-induced emphysema mouse model.
- Open Access
- 29 May 2020
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (12) , 2381-2384
What’s new about pulmonary hyperinflation in mechanically ventilated critical patients
- 29 May 2020
- Published by Springer Nature in Intensive Care Medicine
- Vol. 46 (12) , 2381-2384
Open AccessWhat’s new about pulmonary hyperinflation in mechanically ventilated critical patients
- 1 July 2019
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 317 (1) , R190-R202
Regulation of breathing pattern by IL-10
Proinflammatory cytokines like interleukin-1β (IL-1β) affect the control of breathing. Our aim is to determine the effect of the anti-inflammatory cytokine IL-10 οn the control of breathing. IL-10 knockout mice (IL-10−/−, n = 10) and wild-type mice (IL-10+/+, n = 10) were exposed to the following test gases: hyperoxic hypercapnia 7% CO2-93% O2, normoxic hypercapnia 7% CO2-21% O2, hypoxic hypercapnia 7% CO2-10% O2, and hypoxic normocapnia 3% CO2-10% O2. The ventilatory function was assessed using whole body plethysmography. Recombinant mouse IL-10 (rIL-10; 10 μg/kg) was administered intraperitoneally to wild-type mice ( n = 10) 30 min before the onset of gas challenge. IL-10 was administered in neonatal medullary slices (10–30 ng/ml, n = 8). We found that IL-10−/−mice exhibited consistently increased frequency and reduced tidal volume compared with IL-10+/+mice during room air breathing and in all test gases (by 23.62 to 33.2%, P < 0.05 and −36.23 to −41.69%, P < 0.05, respectively). In all inspired gases, the minute ventilation of IL-10−/−mice was lower than IL-10+/+(by −15.67 to −22.74%, P < 0.05). The rapid shallow breathing index was higher in IL-10−/−mice compared with IL-10+/+mice in all inspired gases (by 50.25 to 57.5%, P < 0.05). The intraperitoneal injection of rIL-10 caused reduction of the respiratory rate and augmentation of the tidal volume in room air and also in all inspired gases (by −12.22 to −29.53 and 32.18 to 45.11%, P < 0.05, respectively). IL-10 administration in neonatal rat ( n = 8) in vitro rhythmically active medullary slice preparations did not affect either rhythmicity or peak amplitude of hypoglossal nerve discharge. In conclusion, IL-10 may induce a slower and deeper pattern of breathing.
- 1 July 2019
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 317 (1) , R190-R202
Regulation of breathing pattern by IL-10
Proinflammatory cytokines like interleukin-1β (IL-1β) affect the control of breathing. Our aim is to determine the effect of the anti-inflammatory cytokine IL-10 οn the control of breathing. IL-10 knockout mice (IL-10−/−, n = 10) and wild-type mice (IL-10+/+, n = 10) were exposed to the following test gases: hyperoxic hypercapnia 7% CO2-93% O2, normoxic hypercapnia 7% CO2-21% O2, hypoxic hypercapnia 7% CO2-10% O2, and hypoxic normocapnia 3% CO2-10% O2. The ventilatory function was assessed using whole body plethysmography. Recombinant mouse IL-10 (rIL-10; 10 μg/kg) was administered intraperitoneally to wild-type mice ( n = 10) 30 min before the onset of gas challenge. IL-10 was administered in neonatal medullary slices (10–30 ng/ml, n = 8). We found that IL-10−/−mice exhibited consistently increased frequency and reduced tidal volume compared with IL-10+/+mice during room air breathing and in all test gases (by 23.62 to 33.2%, P < 0.05 and −36.23 to −41.69%, P < 0.05, respectively). In all inspired gases, the minute ventilation of IL-10−/−mice was lower than IL-10+/+(by −15.67 to −22.74%, P < 0.05). The rapid shallow breathing index was higher in IL-10−/−mice compared with IL-10+/+mice in all inspired gases (by 50.25 to 57.5%, P < 0.05). The intraperitoneal injection of rIL-10 caused reduction of the respiratory rate and augmentation of the tidal volume in room air and also in all inspired gases (by −12.22 to −29.53 and 32.18 to 45.11%, P < 0.05, respectively). IL-10 administration in neonatal rat ( n = 8) in vitro rhythmically active medullary slice preparations did not affect either rhythmicity or peak amplitude of hypoglossal nerve discharge. In conclusion, IL-10 may induce a slower and deeper pattern of breathing.
- Open Access
- 26 November 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (11) , e0207603
Prediction of dysnatremias in critically ill patients based on the law of conservation of mass. Comparison of existing formulae
We aimed to examine the predictive value of a novel mathematical formula based on the law of conservation of mass in calculating sodium changes in intensive care unit patients and compare its performance with previously published formulae. 178 patients were enrolled from 01/2010 to 10/2013. Plasma and urine were collected in two consecutive 8-hour intervals and the sodium was measured. The predicted sodium concentration was calculated based on previous equations and our formula. The two 8-hour period (epoch 1 and 2) results were compared. Variability of predicted values among the measured range of serum sodium levels were provided by Bland-Altman plots with bias and precision statistics. Comparison of the results was performed with the statistical model of the Percentage Similarity. 47.19% patients had dysnatremias. The bias ± SD with 95% limits of agreement for sodium levels were -1.395±3.491 for epoch 1 and -1.623 ±11.1 for epoch 2 period. Bland-Altman analysis for the epoch 1 study period had the following results: -0.8079±3.447 for Adrogué–Madias, 0.56±9.687 for Barsoum–Levine, 0.1412±3.824 for EFWC and 0.294±4.789 for Kurtz–Nguyen formula. The mean similarity, SD and coefficient variation for the methods compared with the measured sodium are: 99.56%, 3.873, 3.89% epoch 1, 99.56%, 1.255, 1.26% for epoch 2, 99.77%, 1.245, 1.26% for Adrogue-Madias, 100.1%, 1.337, 1.34% for Barsoum-Levine, 100.1%, 1.704, 1.7% for Nguyen, 100.1%, 1.370, 1.37% for ECFW formula. The law of conservation of mass can be successfully applied for the prediction of sodium changes in critically ill patients.
- 26 November 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (11) , e0207603
Open AccessPrediction of dysnatremias in critically ill patients based on the law of conservation of mass. Comparison of existing formulae
We aimed to examine the predictive value of a novel mathematical formula based on the law of conservation of mass in calculating sodium changes in intensive care unit patients and compare its performance with previously published formulae. 178 patients were enrolled from 01/2010 to 10/2013. Plasma and urine were collected in two consecutive 8-hour intervals and the sodium was measured. The predicted sodium concentration was calculated based on previous equations and our formula. The two 8-hour period (epoch 1 and 2) results were compared. Variability of predicted values among the measured range of serum sodium levels were provided by Bland-Altman plots with bias and precision statistics. Comparison of the results was performed with the statistical model of the Percentage Similarity. 47.19% patients had dysnatremias. The bias ± SD with 95% limits of agreement for sodium levels were -1.395±3.491 for epoch 1 and -1.623 ±11.1 for epoch 2 period. Bland-Altman analysis for the epoch 1 study period had the following results: -0.8079±3.447 for Adrogué–Madias, 0.56±9.687 for Barsoum–Levine, 0.1412±3.824 for EFWC and 0.294±4.789 for Kurtz–Nguyen formula. The mean similarity, SD and coefficient variation for the methods compared with the measured sodium are: 99.56%, 3.873, 3.89% epoch 1, 99.56%, 1.255, 1.26% for epoch 2, 99.77%, 1.245, 1.26% for Adrogue-Madias, 100.1%, 1.337, 1.34% for Barsoum-Levine, 100.1%, 1.704, 1.7% for Nguyen, 100.1%, 1.370, 1.37% for ECFW formula. The law of conservation of mass can be successfully applied for the prediction of sodium changes in critically ill patients.